VOR BIOPHARMA INC (VORXXXX)
Institutional ownership reported to the SEC as of Q3 2025, across 19 quarters.
1
Reporting holders
$2.6M
Reported value
0.0%
Held as options
-33
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | $2.6M | 53,732 | 0.52% | 17q | -95.0%-$49.7M |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | $2.6M | 53,732 | 0 | 0 | 1 | 0.0% |
| Q2 2025 | 34 | $97.8M | 56,220,199 | 8 | 7 | 12 | 7.5% |
| Q1 2025 | 41 | $43.1M | 60,016,227 | 8 | 7 | 17 | 0.0% |
| Q4 2024 | 46 | $67.4M | 60,735,326 | 10 | 5 | 14 | 0.0% |
| Q3 2024 | 50 | $33.4M | 47,703,842 | 7 | 8 | 18 | 0.0% |
| Q2 2024 | 64 | $54.4M | 54,350,336 | 19 | 15 | 19 | 0.0% |
| Q1 2024 | 62 | $139.3M | 58,759,162 | 10 | 17 | 14 | 0.0% |
| Q4 2023 | 53 | $129.0M | 57,317,525 | 6 | 19 | 7 | 0.0% |
| Q3 2023 | 52 | $121.4M | 57,260,034 | 1 | 13 | 15 | 0.0% |
| Q2 2023 | 62 | $178.1M | 57,589,622 | 21 | 13 | 11 | 0.1% |
| Q1 2023 | 50 | $348.0M | 64,673,757 | 6 | 24 | 6 | 0.0% |
| Q4 2022 | 43 | $365.0M | 54,862,459 | 13 | 18 | 4 | 0.0% |
| Q3 2022 | 46 | $125.5M | 31,536,206 | 8 | 12 | 10 | 0.0% |
| Q2 2022 | 46 | $154.8M | 31,149,655 | 9 | 8 | 15 | 0.0% |
| Q1 2022 | 57 | $187.9M | 31,087,409 | 8 | 11 | 17 | 0.0% |
| Q4 2021 | 60 | $362.1M | 31,163,049 | 9 | 19 | 14 | 0.0% |
| Q3 2021 | 54 | $481.2M | 30,687,555 | 7 | 24 | 14 | 0.0% |
| Q2 2021 | 51 | $571.2M | 30,771,027 | 12 | 10 | 15 | 0.0% |
| Q1 2021 | 49 | $1.3B | 30,710,467 | 49 | 0 | 0 | 0.0% |